Delivery Order SPE2DB20D3505-SPE2DB23FT6D2
Award Date
1/25/23
Potential Completion Date
1/26/23
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The $43,466.61 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 15, 2023. AmerisourceBergen is the child company of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor AmerisourceBergen Corporation, provides for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,545.79 firm fixed price delivery order has a completion date of March 25, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award is for the delivery of Otezla 30 mg tablets (60s) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $7,807.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $14,505.92 for the supply of Otezla 30 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of February 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $22,091.16, is for the delivery of OTEZLA 30 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of OTEZLA 30 mg tablets. This contract, valued at $16,129.12, has an ultimate completion date of May 8, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,656.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Otezla 30 mg tablets. The contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,416.90 firm fixed-price delivery order is for the supply of Otezla 30mg tablets. The contract has an ultimate completion date of October 18, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of OTEZLA 30 mg tablets to the Defense Logistics Agency (DLA). The $3,182.12 firm fixed-price delivery order has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of Otezla 30mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $27,230.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with a period of performance through October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...